Caxton Corp Iveric Bio, Inc. Transaction History

Caxton Corp

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Nov 15, 2021	SELL	$7.07 - $17.5 $1.44 Million - $3.56 Million	-203,414 Closed	0 $0
Q2 2021 Aug 16, 2021	BUY	$5.69 - $7.17 $318,913 - $401,864	56,048 Added 38.03%	203,414 $1.28 Million
Q1 2021 May 17, 2021	BUY	$5.08 - $6.89 $62,915 - $85,332	12,385 Added 9.18%	147,366 $911,000
Q4 2020 Feb 16, 2021	SELL	$5.65 - $7.66 $326,327 - $442,418	-57,757 Reduced 29.97%	134,981 $933,000
Q3 2020 Nov 16, 2020	BUY	$4.01 - $6.29 $272,547 - $427,512	67,967 Added 54.47%	192,738 $1.09 Million
Q2 2020 Aug 14, 2020	BUY	$3.06 - $6.6 $381,799 - $823,488	124,771 New	124,771 $636,000

250K

40K

Ticker ISEE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 118,078,000
Description
IVERIC bio, Inc., a biopharmaceutical company, discovers and develops novel treatments for retinal diseases with a focus on age-related and orphan inherited retinal diseases (IRDs). The company develops Zimura, an inhibitor of complement factor C5 comprising GATHER1, which has completed Phase 2/3 clinical trial; and GATHER2 that is in Phase 3 cl...

Get notified when there are updates to the investment portfolio of Caxton Corp, based on Form 13F filings with the SEC.

Stay updated on Caxton Corp with notifications on news.